1.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition (DSMIV). Washington DC, 1994
2.
Brown SA,Inaba RK,Gillin C,Schuckit MA,Stewart MA,Irwin MR.Alcoholism and affective disorder: clinical course of depressive Symptoms.Am J Psychiatry. 1995;152 (1): 45-52
3.
Reiger DA,Farmer ME,Rae DS,Locker BZ,Keith SJ,Judd LL.Comorbidity of mental disorders with alcohol and other drug abuse.JAMA. 1990;41:2511-2518
4.
El-Guebaly N.Substance abuse and mental disorders: the dual diagnoses concept.Can J Psychiatry. 1990;35:261-267
5.
Cornelius JR,Salloum IH,Mezzich J,Cornelius MD,Fabrega H,Ehler JG.Disproportionate suicidality in patients with comorbid major depression and alcoholism.Am J Psychiatry. 1995;152:358-364
6.
Grant BF,Harford TC.Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey.Drug Alcohol Dependence. 1995;39:197-206
7.
Kitchens JM.Does this patient have an alcohol problem.JAMA. 1994;272 (22): 1782-1787
8.
Milling RN,Faulkner LR,Craig JM.Problems in the recognition and treatment of patients with dual diagnosis.J Substance Abuse Treatment. 1994;11 (3): 267-271
9.
McHugo GJ,Paskus TS,Drake RE.Detection of alcoholism in schizophrenia using the MAST.Alcoholism Clin Exp Rsch. 1993;17 (1): 187-191
10.
Hanson M,Kramer TH,Gross W.Outpatient treatment of adults with coexisting substance use and mental disorders.J Substance Abuse Treatment. 1990;7:109-116
11.
Mason BJ,Kocsis JH,Ritvo EC,Cutler RB.A double-blind, placebo controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression.JAMA. 1996;275 (10): 761-767
12.
Baldessarini RJGoodman and Gilman's: The Pharmacologic Basis of Therapeutics. New York: Pergamon Press; 1991:
13.
Drug facts and comparisons. St. Louis: Wolters Kluwer; 1992:
14.
Litten RZ,Allen JP.Pharmacotherapy for alcoholics with collateral depression or anxiety: An update of research findings.Exp Clin Psycho-pharmacology. 1995;3 (1): 87-93
15.
Nunes EV,McGrath PJ,Quitkin FM,Stewart JP,Harrison T,Tricamo RN.Imipramine treatment of alcoholism with comorbid depression.Am J Psychiatry. 150:963-965
16.
Lyness WH,Smith FL.Influence of dopaminergic and serotonergic neurons on intravenous ethanol self-administration in the rat.Pharmacology, Biochemistry, and Behavior. 1992;42 (1): 187-192
17.
Tollefson GD.Serotonin and Alcohol: Interrelationships.Psychopathology. 1989;22 (suppl 1): 37-48
18.
Naranjo CA,Kadlec KE,Sanhueza P,Woodley-Remus D,Sellers EM.Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers.Clin Pharmacol Ther. 1990;47:490-498
19.
Kranzler HR,Del Boca F,Korner P,Brown J.Adverse effects limit the usefulness of fluvox-amine for the treatment of alcoholism.Substance Abuse Treatment. 1993;10:283-287
20.
Gorelick DA,Paredes A.Effect of fluoxetine on alcohol consumption in male alcoholics.Alcoholism: Clin Exp Rsch. 1992;16 (2): 261-265
21.
Kranzler HR,Burleson JA,Korner P,Del Boca FK,Bohn MJ,Brown J.Placebocontrolled trial of fluoxetine as an adjunct to relapse prevention in alcoholics.Am J Psychiatry. 1995;152 (3): 391-397
22.
Cornelius JR,Salloum IM,Cornelius MD,Perel JM,Thase ME,Ehler JG.Fluoxetine trial in suicidal depressed alcoholics.Psycho-pharmacol Bull. 1993;29:195-199
23.
Cornelius JR,Salloum IM,Cornelius MD,Perel JM,Ehler JG.Preliminary report: double-blind, placebo-controlled study of fluoxetine in depressed alcoholics.Psycho-pharmacol Bull. 1995;31 (2): 297-303
24.
Rosenstein DL,Nelson JC,Jacobs SC.Seizures associated with antidepressants: A review.J Clin Psych. 1993;54 (8): 289-299
25.
Shoaf SE,Linnoila M.Interaction of ethanol and smoking on the pharmacokinetics and pharmacodynamics of psychotropic medications.Psychopharm Bull. 1991;27 (4): 577-594
26.
Barry M.Interactions of drugs with alcohol.Practitioner. 1991;235:270-273
27.
Mattila MJ.Alcohol and drug interactions.Ann Med. 1990;22:363-369
28.
Sands BF,Knapp CM,Ciraulo DA.Medical consequences of alcohol-drug interactions.Alcohol Health Research World. 1993;17 (4): 316-320
29.
Jungnickel PW,Hunnicutt DMApplied therapeutics: the clinical use of drugs. Vancouver: Applied Therapeutics Inc.; 1995:
30.
Larson EW,Olincy A,Rummans TA,Morse RM.Disulfiram treatment of patients with both alcohol dependence and other psychiatric disorders: A review.Alcoholism: Clin Exp Rsch. 1992;16 (1): 125-130
31.
Goyer PF,Brown GL,Minichiello MD,Major LF.Mood-altering effects of disulfiram in alcoholics.J Stud Alcohol. 1984;45 (3): 209-213
32.
Ketter TA,Flockhart DA,Post RM,Denicoff K,Passaglia PJ,Marangell LB.The emerging role of cytochrome P450 3A in psychopharmacology.J Clin Psychopharmacology. 1995;15 (6): 387-398
33.
Harvey AT,Preskorn SH.Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part I.J Clin Psychopharmacology. 1996;16 (4): 273-285
34.
Harvey AT,Preskom SH.Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.J Clin Psychopharmacology. 1996;16 (5): 345-355
Blansjaar BA,Egberts TC.Delirium in a patient treated with disulfiram and tranylcy-promine.Am J Psychiatry. 1995;152 (2): 296
38.
Ciraulo DA.Can disulfiram (antabuse) be safely co-administered with the monoamine oxidase inhibitor (MAOI) antidepressants? De-spite the ability of the major metabolite of disulfiram (diethyldithocarbamate) to inhibit the enzyme dopamine β-hydroxylase and a report of the induction in rats of central motor disturbances, convulsions, and death following the co-administration of tranylcypromine, there appears to be surprisingly little in the literature that directly addresses this question.J Clin Psychopharmacol. 1989;9 (4): 315-316
39.
O'Malley SS,Jaffe AJ,Chang G,Schottenfield RS,Meyer RE,Rounsaville B.Naltrexone and coping skills therapy for alcohol dependence: a controlled study.Arch Gen Psychiatry. 1992;49:881-887
40.
Swift RM,Whelihan W,Kuznetsov O,Buongiorno G,Hsuing H.Naltrexone-induced alterations in human ethanol intoxication.Am J Psychiatry. 1994;151 (10): 1463-1467
41.
Volpicelli JR,Alterman AI,Hayashida M,O'Brien CP.Naltrexone in the treatment of alcohol dependence.Arch Gen Psychiatry. 1992;49:876-880
42.
Volpicelli JR,Clay KL,Watson NT,O'Brien CP.Naltrexone in the treatment of alcoholism: predicting response to treatment.J Clin Psychiatry. 1995;56 (suppl 7): 39-44
43.
Volpicelli JR,Watson NT,King AC,Sherman CE,O'Brien CP.Effect of naltrexone on alcohol “high” in alcoholics.Am J Psychiatry. 1995;152 (4): 613-615
44.
O'Malley SS,Jaffe AJ,Rode S,Rounsaville BJ.Experience of a “slip” among alcoholics treated with naltrexone or placebo.Am J Psychiatry. 1996;153 (2): 281-283
45.
45.Package Insert. DuPont, 1995
46.
Hollister LE,Johnson K,Boukhabza D,Gillespie HK.Aversive effects of naltrexone in subjects not dependent on opiates.Drug and Alcohol Dependence. 1981;8:37-41
